QA: Blueprint Medicines Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2024_Blueprint_Medicines_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 808,393,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 41,959,000
3 remainder_Assets 198,898,000
4 LiabilitiesCurrent 214,923,000
5 LiabilitiesNoncurrent 92,756,000
6 remainder_Liabilities 610,962,000
7 CostOfGoodsAndServicesSold 8,341,001
8 SellingGeneralAndAdministrativeExpense 583,591,020
9 ResearchAndDevelopmentExpense 431,965,775
10 remainder_Expenses 3,995,718
11 remainder_Revenues 234,076,827
12 remainder_NetIncome -25,664,926
13 remainder_ComprehensiveNetIncome -6,303,538
  yvar yval
0 Assets 1,049,250,000
1 Liabilities 918,641,000
2 Expenses 1,027,893,514
3 Revenues 234,076,827
4 StockholdersEquity 130,609,000
5 NetIncome -819,481,613
6 ComprehensiveNetIncome -822,633,382
7 BaseVar 1,630,914,902
8 EconomicCapitalRatiobeforeLimitedLiability -0.547
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time